Select Medical Holdings Corp. Files 8-K
Ticker: SEM · Form: 8-K · Filed: Nov 25, 2025 · CIK: 1320414
Sentiment: neutral
Topics: disclosure, financials
TL;DR
SELECT MEDICAL HOLDINGS CORP filed an 8-K on Nov 25, 2025, for events on Nov 24, 2025. Standard disclosure.
AI Summary
Select Medical Holdings Corp. announced a Regulation FD Disclosure and filed financial statements and exhibits on November 25, 2025. The filing pertains to events reported as of November 24, 2025. The company, headquartered in Mechanicsburg, PA, is involved in the hospital services sector.
Why It Matters
This 8-K filing indicates that Select Medical Holdings Corp. is providing updated disclosures and financial information to the public, which is crucial for investors to assess the company's current status.
Risk Assessment
Risk Level: low — This filing is a routine disclosure and does not appear to contain any immediately alarming or significant negative news.
Key Numbers
- 001-34465 — SEC File Number (Identifies the company's filing history with the SEC.)
- 20-1764048 — I.R.S. Employer Identification No. (Company's tax identification number.)
Key Players & Entities
- SELECT MEDICAL HOLDINGS CORP (company) — Registrant
- November 24, 2025 (date) — Earliest event reported date
- November 25, 2025 (date) — Filing date
- Mechanicsburg, PA (location) — Company headquarters
FAQ
What specific items are being disclosed under Regulation FD?
The filing indicates a 'Regulation FD Disclosure' but does not specify the exact content of the disclosure within the provided text.
What are the key financial statements and exhibits being filed?
The filing mentions 'Financial Statements and Exhibits' but the specific documents are not detailed in the provided excerpt.
What is the primary business of Select Medical Holdings Corp?
Select Medical Holdings Corp. is classified under 'SERVICES-HOSPITALS [8060]' according to its Standard Industrial Classification.
When was Select Medical Holdings Corp. incorporated?
The company was incorporated in Delaware.
What is the principal executive office address for Select Medical Holdings Corp?
The principal executive offices are located at 4714 Gettysburg Road, Mechanicsburg, PA 17055.
Filing Stats: 574 words · 2 min read · ~2 pages · Grade level 11.1 · Accepted 2025-11-25 08:15:41
Key Financial Figures
- $0.001 — ch registered Common Stock, par value $0.001 per share SEM New York Stock Exchange
Filing Documents
- tm2532134d1_8k.htm (8-K) — 29KB
- tm2532134d1_ex99-1.htm (EX-99.1) — 11KB
- tm2532134d1_ex99-1img001.jpg (GRAPHIC) — 28KB
- tm2532134d1_ex99-1img002.jpg (GRAPHIC) — 14KB
- 0001104659-25-115701.txt ( ) — 264KB
- sem-20251124.xsd (EX-101.SCH) — 3KB
- sem-20251124_lab.xml (EX-101.LAB) — 33KB
- sem-20251124_pre.xml (EX-101.PRE) — 22KB
- tm2532134d1_8k_htm.xml (XML) — 4KB
01 Regulation FD Disclosure
Item 7.01 Regulation FD Disclosure. On November 24, 2025, Select Medical Holdings Corporation (the " Company ") issued a press release (the " Press Release ") regarding the non-binding indication of interest submitted to the Board of Directors of the Company by Robert A. Ortenzio, the Company's Executive Chairman, Co-Founder and Director, as publicly disclosed in a Schedule 13D filed with the Securities and Exchange Commission by Mr. Ortenzio, the Estate of Rocco A. Ortenzio, and Mr. Jackson, as a group, on November 24, 2025. A copy of the Press Release is attached as Exhibit 99.1 to this report and incorporated herein by reference. The information in this Item 7.01 in this Current Report on Form 8-K and Exhibit 99.1 attached hereto shall not be deemed to be "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the " Exchange Act "), or otherwise subject to the liabilities of that section, nor shall it be deemed to be incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly set forth by specific reference in such filing.
Financial Statements and Exhibits
Financial Statements and Exhibits. (d) Exhibits. Exhibit Number Description 99.1 Press Release, dated November 24, 2025, acknowledging Executive Chairman's Take-Private Proposal. 104 Cover Page Interactive Data File (embedded within the Inline XBRL document) SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. SELECT MEDICAL HOLDINGS CORPORATION Date: November 25, 2025 By: /s/ John F. Duggan John F. Duggan Executive Vice President, General Counsel and Secretary